Dr Reddy’s inks pact with Gilead for Covid-19 drug

Dr. Reddy's Laboratories Ltd has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead) on Remdesivir. As part of the ag

from Business Line - Companies https://ift.tt/3fj6XHn